mutations, in whom rituximab appears to get small added price.59 Other genomic subgroups, such as clients with BIRC3This methylation profile is already obtained within the MBL stage3 and stays somewhat stable after some time. However, some CLL have intratumor variability in selected regions, which can change the expression of numerous genes and fac